HFSA 2018: Sacubitril/Valsartan Therapy Improves Several Measures of Chronic HFrEF
In real-world experience, initiating sacubitril/valsartan in patients with chronic HFrEF led to measurable improvement.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.